Smith Karen L. Insider Trades

Insider Trading History

Track insider trading activity for Smith Karen L.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Skye Bioscience
Skye Bioscience SKYE
Director
Holding Value $52.5k 75,000 shares
Last Trade
Mar 31, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$46.5k 75,000 shares
$0.62
$0.70
Skye Bioscience
Skye Bioscience SKYE
Director
Holding Value $24.5k 35,000 shares
Last Trade
Feb 06, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$28.7k 35,000 shares
$0.82
$0.70
Sangamo Therapeutics
Sangamo Therapeutics SGMO
Director
Holding Value $7.46k 102,100 shares
Last Trade
Jun 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$25k 50,000 shares
$0.50
$0.07
Context Therapeutics
Context Therapeutics CNTX
Director
Holding Value $80.5k 123,500 shares
Last Trade
Jun 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$80.3k 123,500 shares
$0.65
$0.65
Skye Bioscience
Skye Bioscience SKYE
Director
Holding Value $24.5k 35,000 shares
Last Trade
Feb 24, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$101k 35,000 shares
$2.89
$0.70
Aurinia Pharmaceuticals
Aurinia Pharmaceuticals AUPH
Director
Holding Value $444k 24,807 shares
Last Trade
Nov 21, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$154k 18,641 shares
$8.24
$17.88
Aurinia Pharmaceuticals
Aurinia Pharmaceuticals AUPH
Director
Holding Value $227k 12,672 shares
Last Trade
Nov 11, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$44.2k 5,241 shares
$8.43
$17.88
Aurinia Pharmaceuticals
Aurinia Pharmaceuticals AUPH
Director
Holding Value $0 0 shares
Last Trade
Nov 08, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$149k 17,913 shares
$8.32
$17.88
Aurinia Pharmaceuticals
Aurinia Pharmaceuticals AUPH
Director
Holding Value $320k 17,913 shares
Last Trade
Nov 08, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$149k 17,913 shares
$8.32
$17.88
Skye Bioscience
Skye Bioscience SKYE
Director
Holding Value $49k 70,000 shares
Last Trade
Oct 28, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$361k 70,000 shares
$5.15
$0.70
Context Therapeutics
Context Therapeutics CNTX
Director
Holding Value $12.6k 19,315 shares
Last Trade
Sep 04, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$46.9k 19,315 shares
$2.43
$0.65
Skye Bioscience
Skye Bioscience SKYE
Director
Holding Value $28k 40,000 shares
Last Trade
Jul 02, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$302k 40,000 shares
$7.56
$0.70
Sangamo Therapeutics
Sangamo Therapeutics SGMO
Director
Holding Value $5.64k 77,100 shares
Last Trade
Jun 04, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$28.5k 50,000 shares
$0.57
$0.07
Aurinia Pharmaceuticals
Aurinia Pharmaceuticals AUPH
Director
Holding Value $518k 28,959 shares
Last Trade
Aug 18, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$275k 28,959 shares
$9.49
$17.88
Talaris Therapeutics
Talaris Therapeutics TALS
Director
Holding Value $55.8k 20,500 shares
Last Trade
Jun 13, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$2.72
Tourmaline Bio
Tourmaline Bio TRML
Director
Holding Value $984k 20,500 shares
Last Trade
Jun 13, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$521k 20,500 shares
$25.40
$47.98
Sangamo Therapeutics
Sangamo Therapeutics SGMO
Director
Holding Value $3.81k 52,100 shares
Last Trade
Jun 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$30.8k 27,750 shares
$1.11
$0.07
Quince Therapeutics
Quince Therapeutics QNCX
Chief Medical Officer
Holding Value $218k 225,000 shares
Last Trade
Feb 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$212k 225,000 shares
$0.94
$0.97
Talaris Therapeutics
Talaris Therapeutics TALS
Director
Holding Value $39.4k 14,501 shares
Last Trade
Jun 09, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$2.72
Cortexyme
Cortexyme CRTX
Chief Medical Officer
Holding Value $380k 194,690 shares
Last Trade
May 19, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$562k 170,354 shares
$3.30
$1.95

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up